PubMed (OMIM) for id: 382914

Year	Number of Results
1990	2
1991	3
1992	6
1993	7
1994	11
1995	16
1996	29
1997	19
1998	12
1999	21
2000	12
2001	17
2002	15
2003	15
2004	4
2005	3
2024	0

1

Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells.

Furuta S, Jiang X, Gu B, Cheng E, Chen PL, Lee WH. Furuta S, et al. Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9176-81. doi: 10.1073/pnas.0503793102. Epub 2005 Jun 20. Proc Natl Acad Sci U S A. 2005. PMID: 15967981 Free PMC article.

2

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A. Farmer H, et al. Nature. 2005 Apr 14;434(7035):917-21. doi: 10.1038/nature03445. Nature. 2005. PMID: 15829967 Free article.

3

Breast cancer risks for BRCA1/2 carriers.

Easton DF, Hopper JL, Thomas DC, Antoniou A, Pharoah PD, Whittemore AS, Haile RW. Easton DF, et al. Science. 2004 Dec 24;306(5705):2187-91; author reply 2187-91. doi: 10.1126/science.306.5705.2187c. Science. 2004. PMID: 15622557 No abstract available.

4

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.

Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Dinulescu DM, et al. Nat Med. 2005 Jan;11(1):63-70. doi: 10.1038/nm1173. Epub 2004 Dec 26. Nat Med. 2005. PMID: 15619626

5

Identification of BRCA1-IRIS, a BRCA1 locus product.

ElShamy WM, Livingston DM. ElShamy WM, et al. Nat Cell Biol. 2004 Oct;6(10):954-67. doi: 10.1038/ncb1171. Epub 2004 Sep 26. Nat Cell Biol. 2004. PMID: 15448696

6

Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure.

Wang X, Wang RH, Li W, Xu X, Hollander MC, Fornace AJ Jr, Deng CX. Wang X, et al. J Biol Chem. 2004 Jul 9;279(28):29606-14. doi: 10.1074/jbc.M312279200. Epub 2004 May 3. J Biol Chem. 2004. PMID: 15123655 Free article.

7

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. King MC, et al. Science. 2003 Oct 24;302(5645):643-6. doi: 10.1126/science.1088759. Science. 2003. PMID: 14576434

8

The BRCT domain is a phospho-protein binding domain.

Yu X, Chini CC, He M, Mer G, Chen J. Yu X, et al. Science. 2003 Oct 24;302(5645):639-42. doi: 10.1126/science.1088753. Science. 2003. PMID: 14576433

9

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.

Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, Greene MH, Maslansky B, Fischbein A, Gruber SB, Rennert G, Ronchetti RD, Hewitt SM, Struewing JP, Iscovich J. Giusti RM, et al. J Med Genet. 2003 Oct;40(10):787-92. doi: 10.1136/jmg.40.10.787. J Med Genet. 2003. PMID: 14569130 Free PMC article. No abstract available.

10

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.

Díez O, Osorio A, Durán M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, Vega A, Campos B, Rodríguez-López R, Velasco E, Chaves J, Díaz-Rubio E, Jesús Cruz J, Torres M, Esteban E, Cervantes A, Alonso C, San Román JM, González-Sarmiento R, Miner C, Carracedo A, Eugenia Armengod M, Caldés T, Benítez J, Baiget M. Díez O, et al. Hum Mutat. 2003 Oct;22(4):301-12. doi: 10.1002/humu.10260. Hum Mutat. 2003. PMID: 12955716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

189 results

Results by year